You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

PENICILLIN G POTASSIUM IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Penicillin G Potassium In Plastic Container patents expire, and when can generic versions of Penicillin G Potassium In Plastic Container launch?

Penicillin G Potassium In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in PENICILLIN G POTASSIUM IN PLASTIC CONTAINER is penicillin g potassium. There are ninety-two drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the penicillin g potassium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Penicillin G Potassium In Plastic Container

A generic version of PENICILLIN G POTASSIUM IN PLASTIC CONTAINER was approved as penicillin g potassium by SANDOZ on August 30th, 2002.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PENICILLIN G POTASSIUM IN PLASTIC CONTAINER?
  • What are the global sales for PENICILLIN G POTASSIUM IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for PENICILLIN G POTASSIUM IN PLASTIC CONTAINER?
Summary for PENICILLIN G POTASSIUM IN PLASTIC CONTAINER
Drug patent expirations by year for PENICILLIN G POTASSIUM IN PLASTIC CONTAINER
Recent Clinical Trials for PENICILLIN G POTASSIUM IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Haining Health-Coming Biotech Co., Ltd.Phase 2
Alphacait, LLCPhase 2
Phillip Brian SmithPhase 1

See all PENICILLIN G POTASSIUM IN PLASTIC CONTAINER clinical trials

Pharmacology for PENICILLIN G POTASSIUM IN PLASTIC CONTAINER

US Patents and Regulatory Information for PENICILLIN G POTASSIUM IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare PENICILLIN G POTASSIUM IN PLASTIC CONTAINER penicillin g potassium INJECTABLE;INJECTION 050638-001 Jun 25, 1990 RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Baxter Hlthcare PENICILLIN G POTASSIUM IN PLASTIC CONTAINER penicillin g potassium INJECTABLE;INJECTION 050638-002 Jun 25, 1990 RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Baxter Hlthcare PENICILLIN G POTASSIUM IN PLASTIC CONTAINER penicillin g potassium INJECTABLE;INJECTION 050638-003 Jun 25, 1990 RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

PENICILLIN G POTASSIUM IN PLASTIC CONTAINER Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Penicillin G Potassium in Plastic Containers

Market Overview

The market for Penicillin G Potassium, particularly in plastic containers, is part of the broader penicillin drug market, which is experiencing significant growth driven by several key factors.

Global Penicillin Drug Market Size and Growth

The global penicillin drug market was valued at $8.4 billion in 2022 and is projected to reach $12.1 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 3.7% from 2023 to 2032[3].

Penicillin G Potassium Market Specifics

The Penicillin G Potassium market, a subset of the penicillin drug market, is also expected to see substantial growth. This market is forecasted to increase at a CAGR of 3 to 5 percent from 2023 to 2031, driven by its applications in various medical fields[1].

Market Segmentation

By Application

Penicillin G Potassium is segmented based on its applications, including 6-APA, 7-ADCA, GCLE, and Penicillin G Sodium. These applications are crucial in the production of other antibiotics and pharmaceuticals[1].

By Product

The market is also segmented by product purity, typically 95% and 99% purity levels. The demand for high-purity Penicillin G Potassium is increasing due to its critical role in medical treatments[1].

By Route of Administration

The parenteral segment, which includes intravenous and intramuscular injections, dominates the market in terms of revenue. However, the oral segment is anticipated to grow rapidly due to its cost-effectiveness and ease of administration[3].

Market Drivers

Increasing Prevalence of Bacterial Infections

The rise in bacterial infections globally is a significant driver for the penicillin market. Penicillin G Potassium is effective against a wide range of bacteria, including Streptococcus pneumoniae, Streptococcus pyogenes, and some gram-negative bacteria[3].

Advancements in Drug Formulation and Delivery

Improvements in drug formulation, manufacturing, and delivery systems enhance the accessibility and convenience of Penicillin G Potassium, contributing to market growth[3].

Expanding Global Population and Aging Demographics

The growing global population, particularly the aging demographics, increases the susceptibility to infections, thereby driving the demand for penicillin drugs[3].

Market Restraints

Antimicrobial Resistance

The increasing resistance to antibiotics, including penicillin, poses a significant challenge to the market. This resistance necessitates the development of new antibiotics and combination therapies[3].

Regulatory and Safety Concerns

Stringent regulatory requirements and safety concerns, such as the potential for allergic reactions and the need for careful dosing, especially in patients with renal impairment, can restrain market growth[2].

Financial Trajectory

Market Size Forecast

The Penicillin G Potassium market is expected to experience sustained growth, with market size forecasts indicating a significant expansion from 2023 to 2031. The market is valued in millions of USD and is segmented by geographical regions, including North America, Europe, Asia-Pacific, South America, and the Middle-East and Africa[1].

Revenue and CAGR

The global penicillin drug market, which includes Penicillin G Potassium, is projected to grow at a CAGR of 3.7% from 2023 to 2032. This growth rate is indicative of the robust demand for penicillin-based treatments[3].

Regional Analysis

North America

North America is a key region driving the growth of the penicillin market due to the high prevalence of bacterial infections and the burden of antimicrobial resistance. The region's advanced healthcare infrastructure also contributes to the market's expansion[3].

Asia-Pacific

The Asia-Pacific region is anticipated to witness notable growth during the forecast period, driven by investments in R&D for penicillin medications, a large population base, and increasing access to healthcare services[3].

Key Players

Major players in the penicillin drug market, including Abbott Laboratories, Alkem Laboratories Ltd., Cipla Ltd, GlaxoSmithKline plc, Pfizer Inc., and others, are focusing on expanding their product portfolios and improving drug formulations to capture a larger market share[3].

Technological and Manufacturing Trends

Improved Manufacturing Processes

Advancements in manufacturing processes have enhanced the purity and stability of Penicillin G Potassium, making it more effective and safer for use. These improvements also reduce production costs and increase efficiency[4].

Environmental and Safety Regulations

The chemical industry, including the production of Penicillin G Potassium, is heavily influenced by environmental and safety regulations. Compliance with these regulations is crucial for market players to ensure sustainable growth[4].

Consumer Behavior and Healthcare Infrastructure

Increasing Awareness and Adoption

The growing awareness among consumers about the use of combination medications for treating bacterial infections is driving the demand for Penicillin G Potassium. Improved healthcare infrastructure, especially in developing regions, also enhances access to diagnosis and treatment, contributing to market growth[3].

Role of Pharmacists and Healthcare Professionals

Pharmacists and healthcare professionals play a critical role in the distribution and administration of Penicillin G Potassium. Their expertise in ensuring appropriate dosages and counseling on potential side effects is vital for the market's expansion[3].

Challenges and Opportunities

Challenges

  • Antimicrobial Resistance: The increasing resistance to antibiotics is a significant challenge that necessitates the development of new and more effective antibiotics.
  • Regulatory Hurdles: Stringent regulatory requirements can slow down the approval and market entry of new penicillin-based treatments.
  • Renal Impairment: The need for careful dosing in patients with renal impairment can complicate treatment protocols[2][3].

Opportunities

  • R&D Investments: Investments in research and development can lead to the creation of new and more effective penicillin-based treatments.
  • Expanding Healthcare Access: Improving healthcare infrastructure in developing regions can increase access to penicillin treatments.
  • Combination Therapies: The development of combination medications that include Penicillin G Potassium can offer better treatment outcomes and drive market growth[3][4].

Key Takeaways

  • The Penicillin G Potassium market is expected to grow at a CAGR of 3 to 5 percent from 2023 to 2031.
  • The market is driven by the increasing prevalence of bacterial infections, advancements in drug formulation, and expanding global population.
  • Key challenges include antimicrobial resistance, regulatory hurdles, and the need for careful dosing in patients with renal impairment.
  • Opportunities for growth include R&D investments, expanding healthcare access, and the development of combination therapies.

FAQs

What is the projected market size of the global penicillin drug market by 2032?

The global penicillin drug market is projected to reach $12.1 billion by 2032[3].

What is the CAGR of the Penicillin G Potassium market from 2023 to 2031?

The Penicillin G Potassium market is expected to grow at a CAGR of 3 to 5 percent from 2023 to 2031[1].

Which segment dominates the penicillin drug market in terms of revenue?

The parenteral segment, which includes intravenous and intramuscular injections, dominates the market in terms of revenue[3].

What are the main drivers of the Penicillin G Potassium market?

The main drivers include the increasing prevalence of bacterial infections, advancements in drug formulation, and the expanding global population[3].

How does renal impairment affect the dosing of Penicillin G Potassium?

Renal impairment requires careful dosing adjustments due to the delayed renal clearance of Penicillin G Potassium. Dosage reductions are necessary in patients with severe renal impairment, especially when accompanied by hepatic disease[2].

Sources

  1. Market Research Intellect: Global Penicillin G Potassium First Crystals Sales Market Size Forecast.
  2. FDA: Penicillin G Potassium Injection, USP.
  3. Allied Market Research: Penicillin Drug Market Size, Share & Growth Report, 2032.
  4. Cognitive Market Research: Global Penicillin G Potassium Market Report 2024 Edition.
  5. Pfizer Medical Information: PFIZERPEN® (penicillin G potassium) Clinical Pharmacology.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.